OVERCOMING

LIMITS

ANNUAL REPORT 2017

EN     PT

COMMITMENT

TO ACCOUNTABILITY

Practice that reinforces transparency with our stakeholders, the 2017 Annual Report, portrays Aché’s performance from a transversal perspective that considers the financial, socio-environmental, governance and management spheres.

For the second consecutive year, the Aché Annual Report follows the international reporting methodology of the Global Reporting Initiative (GRI).

In a continuous effort to improve the reporting process, this year we incorporated the latest version of the GRI guidelines - Standards - in the Core option. The document also considers the benchmarks specific for the health sector developed by the Sustainability Accounting Standards Board (Sasb) and the integrated reporting principles defined by the International Integrated Reporting Council (IIRC). [GRI 102-52 e 102-54]

We presented our main results in the five pillars of the current Strategic Planning and the performance achieved in 2017 in the topics deemed most relevant to the Company, identified in a process of consultation and engagement conducted in 2016 (see chapter Sustainability), in addition to the Financial Statements.

With the publication, we seek to highlight our trajectory in favor of business growth and a management model increasingly guided by sustainability and creation of value. [GRI 102-46]

Relevant topics and affected audiences

[GRI 102-44, GRI 102-46, GRI 102-47 e GRI 103-1]

MATERIAL TOPIC¹IMPACTS²GRI TOPICSINDICATOR GRICHAPTER³
.
.
Innovation in processes, research and
development of products
Consumers
Healthcare professionals
Society
NoneNoneInnovation
Access to drugsConsumers
Society Distributors
Points of sale
NoneNoneCostumer Focus

Customers
Contribution and impacts on healthConsumers
Healthcare professionals
Society
NoneNone

201-1
Innovation
Growth
Customers
.
.
Operational excellenceAché
Distributors
Economic
performance
201-1Operational Excellence
Reverse logistics of
pharmaceutical products
Environment
Distributors
Aché
Materials301-2
301-3
Operational Excellence
.
.
Ethical behaviorSociety

Government
Anticorruption205-3Strategy and Management
Socioeconomic
compliance
419-1Growth
Strategy and Management
Pricing of productsCustomers
Distributors
Points of sale
NoneNoneCostumer Focus
Brand presence in the marketAché
Customers
NoneNoneProfile
Growth
.
.
Product quality and safetyCustomer
Suppliers
Healthcare professionals
Consumers health
and safety
416-1Innovation
Operational excellenceEnvironmentEnergy302-1
302-3
Operational Excellence
AchéWater303-1
303-3
Operational Excellence
Effluents and wastes306-2Operational Excellence
TraceabilityConsumersNoneNão háConsumers focus

HEALTH

DISTRIBUTION AND LOGISTICS

ETHICS AND BUSINESS

OPERATION

¹Topics grouped by thematic fields, according to methodology adopted by Aché.
²Information on where the main positive and negative impacts related to the topic are concentrated.
³Chapter in this report where the topic is addressed more in-depth.

GRI CONTENT

INDEX

GRI 101 FOUNDATION 2016

GRI 102 GENERAL DISCLOSURES 2016 (FOR ALL OCCURRENCES)

PROFILE

STRATEGY

ETHICS AND INTEGRITY

GOVERNANCE

GRI 102 GENERAL DISCLOSURES 2016 (FOR ALL OCCURRENCES)

ENGAGEMENT OF STAKEHOLDERS

REPORTING PRACTICES

GRI 103 MANAGEMENT APPROACH (FOR ALL OCCURRENCES)

TOPIC-SPECIFIC DISCLOSURES: ECONOMIC

201 ANTICORRUPTION 2016 (FOR ALL OCCURRENCES)

205 COMBATE À CORRUPÇÃO 2016 (TODAS AS OCORRÊNCIAS)

TOPIC-SPECIFIC DISCLOSURES: ENVIRONMENTAL

301 MATERIALS 2016 (FOR ALL OCCURRENCES)

302 ENERGY 2016 (FOR ALL OCCURRENCES)

303 WATER 2016

306 TEFFLUENTS AND WASTES 2016

TOPIC-SPECIFIC DISCLOSURES: SOCIAL

416 CUSTOMER HEALTH AND SAFETY 2016

416 SOCIOECONOMIC CONFORMITY

DISCLOSUREOMISSIONSPAGE/ANSWER
102-1 NameProfile
102-2 Activities, brands, products and servicesThe full description can be in the Chapter profile. None of the
products marketed is the target of questions by the company’s
stakeholders nor has it been banned in its markets.
102-3 Location of the head officeProfile
102-4 Location of the operationsProfile
102-5 Type and legal nature of the propertyProfile
102-6 Markets in which it operatesProfile
102-7 SizeProfile
102-8 Employees and other workersProfile / Aché Generator
102-9 Supply chainOperational Excellence
102-10 Significant changes in the organization and in its supply chainNone
102-11 Precautionary principleAché does not formally adopt the precautionary principle, but the decision-making
process is strongly supported by a risk management system and involves the
search for mitigation of impacts. Further information on risk management can
be found in chapter Strategy and management.
102-12 External initiativeIn 2017, the external initiatives that will be supported by Aché were mapped out.
The supports will be made effective as of 2018.
102-13 Participation in associationsSustainability
102-14 Message from the presidentMessage from the CEO
102-16 Values, principles, standards and rules of conductProfile/ Strategy and Management
102-18 Governance structureStrategy and Management
DISCLOSUREOMISSIONSPAGE/ANSWER
102-40 List of groups of stakeholdersSustainability
102-41 Collective bargaining agreementsThe agreements involve 99% of employees.
102-42 Identification and selection of stakeholders Sustentabilidade
102-43 Approach to engage stakeholdersThe approach focused on the report is described in the Sustainability in chapter
Sustainability, while day-to-day management of the relationship with the various
stakeholders is discussed in chapter Aché Generation (employees) in chapter
Operational Excellence (supplierse), in chapter Customer Focus (healthcare
professionals, clientes and consumers) and in chapter Sustainability (community).
102-44 Main topics and concerns raisedReport
102-45 Entities included in the consolidated financial statementsThe scope of GRI information contained in the report is restricted to the companies
that are part of Aché in Brazil. Aché Internacional Ltda., based in the British Virgin
Islands,which is included in the Financial Statements, was considered only in the
economic indicators reported and which are derived from the Financial Statements.
102-46 Definition of the content and limitsReport
102-47 List of material topicsReport
102-48 Reformulation of informationNone
102-49 Changes in elaboration of the reportNone
102-50 Period covered by the reportJanuary 1 to December 31, 2017
102-51 Date of the last2017
102-52 Publishing cycleAnnual
102-53 Contact in case of doubtsrelatorioanual@ache.com.br
102-54 Declaration of compliance with the GRI StandardThis report has been prepared in accordance with the GRI standards: core option.
102-55 GRI Table of Contents Report
102-56 External verificationThere was no external verification.
DISCLOSUREOMISSIONSPAGE/ANSWER
103-1 Material themes and limitsReport
103-2 Management approachSustainability
103-3 Management approach evaluationSustainability
201-1 Direct economic valueSustainability
103-1 Material themes and limits Report
103-2 Management approachStrategy and Management
103-3 Management approach evaluationStrategy and Management
205-3 Confirmed cases of corruption and measures takenStrategy and Management
DISCLOSUREOMISSIONSPAGE/ANSWER
103-1 Material themes and limitsReport
103-2 Management approachOperational Excellence
103-3 Management approach evaluationOperational Excellence
301-2 Recycled input materials usedOperational Excellence
301-3 Recovered products and packagesOperational Excellence
103-1 Material themes and limitsReport
103-2 Management approachOperational Excellence
103-3 Management approach evaluationOperational Excellence
302-1 Energy consumption in the organizationOperational Excellence
302-3 Energy intensityOperational Excellence
103-1 Material themes and limitsReport
103-2 Management approachOperational Excellence
103-3 Management approach evaluationOperational Excellence
303-1 Water consumption by sourceOperational Excellence
303-3 Recycled and reused waterHere is currently no initiative, but Aché is studying projects to implement reuse
systems at the Guarulhos unit and at the new plant in Pernambuco.
103-1 Material themes and limits Report
103-2 Management approachOperational Excellence
103-3 Management approach evaluationOperational Excellence
306-2 Waste by type and method of disposalOperational Excellence
DISCLOSUREOMISSIONSPAGE/ANSWER
103-1 Material themes and limits Report
103-2 Management approachOperational Excellence
103-3 Management approach evaluationOperational Excellence
416-1 Assessment of impacts on products and servicesOperational Excellence
103-1 Material themes and limitsReport
103-2 Management approachStrategy and Management
103-3 Management approach evaluationStrategy and Management
419-1 Cases of noncompliance with laws and rulesThere were no fines or monetary sanctions for nonconformity with laws
and regulations in the social and economic spheres.

Cranberry: active ingredient of the product Cysberry, Achevita line

CREDITS

Board of Directors

Vânia Nogueira de Alcantara Machado – CEO

Adriano Alvim de Oliveira - Executive Director of Operations

Cristiane Zanquetta – Director of the Institutional and Specialty Care Business Unit

Francisco Luiz Malena – Diretor de Inteligência Competitiva | Director of Competitive Intelligence

Gabriela Mallmann – Executive director of Quality, Regulatory Affairs and PMO

Joaquim Rocha – Executive director of Human Resources and Sustainability

Luciana Gualda – Legal executive director

Manoel Arruda Nascimento Neto – Executive director of Prescription Marketing and Orion Demand Generation

Marcelo Neri – Executive director of Prescription Marketing and Pegasus Demand Generation

Márcio Reis de Freitas – Industrial Director

Mônica Monteiro Branco Ferreira – Director of the Dermatology Business Unit

Sidinei Righini – Financial executive Director

Stephani Saverio – Director of the Innovation Center

Vânia Nogueira de Alcantara Machado – Executive director of Sales and OTC and Generics Business Units

General coordination

Communication and Social Responsibility Management

Financial statements

Financial Board

Editorial coordination

CDI Comunicação Corporativa

Design

Aché | Mauro Ogino
CDI Comunicação Corporativa | Renata Maneschy e Vivian Garcia

GRI Consultancy

Judith Mota

Text

Talita Fusco

Photography

Mauricio Paião Vargas

Cover

Robson Mathias Duarte

Review

Ivana Traversim

Translation

Ricardo Spósito

 

Aché Laboratórios Farmacêuticos S.A.
Rodovia Presidente Dutra, km 222,2 – Porto da Igreja – Guarulhos – SP – 07034-904
Tel.: 55 11 2608-6000

Aché

Right Menu IconMENU